Free Trial

Fennec Pharmaceuticals (TSE:FRX) Upgraded by Stephens to "Strong-Buy" Rating

Fennec Pharmaceuticals logo with Medical background

Fennec Pharmaceuticals (TSE:FRX - Get Free Report) was upgraded by Stephens to a "strong-buy" rating in a research report issued on Monday,Zacks.com reports.

Fennec Pharmaceuticals Stock Up 16.9 %

Fennec Pharmaceuticals stock traded up C$0.96 during mid-day trading on Monday, reaching C$6.65. The stock had a trading volume of 5,639 shares, compared to its average volume of 1,852. The company has a market capitalization of C$181.94 million, a price-to-earnings ratio of 66.50 and a beta of 0.25. The company has a debt-to-equity ratio of 1,040.68, a current ratio of 8.02 and a quick ratio of 10.17. Fennec Pharmaceuticals has a one year low of C$5.65 and a one year high of C$15.43. The company has a 50-day moving average price of C$6.41 and a two-hundred day moving average price of C$8.03.

About Fennec Pharmaceuticals

(Get Free Report)

Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.

Further Reading

→ My #1 Pre IPO Trade for 2025 – NAME and TICKER (From Wyatt Investment Research) (Ad)

Should you invest $1,000 in Fennec Pharmaceuticals right now?

Before you consider Fennec Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fennec Pharmaceuticals wasn't on the list.

While Fennec Pharmaceuticals currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines